A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MA / membrane antigen

[Related PubMed/MEDLINE]
Total Number of Papers: 75
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MA  (>> Co-occurring Abbreviation)
Long Form:   membrane antigen
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus. ANA, EA, EBV, ELISA, EPs, HCs, IgG, KLH, LMP, SLE
2015 EBV-Specific Immune Response: Early Research and Personal Reminiscences. BL, EA, EBNA, EBV, IM, NPC
2003 Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection. EBERs, EBNA1, EBV, LMP1, LMP2A, NPL, VCA
2001 [Expression of Epstein-Barr virus membrane antigen induces lymphoma in transgenic mice]. EBV
1998 [Expression of Epstein-Barr virus membrane antigen in CHO cell]. EBV
1996 Detection of Epstein-Barr virus-infected mucosal lymphocytes in nasal polyps. EBER, EBNA, EBV, LMP, VCA
1996 Molecular diagnosis of nasopharyngeal carcinoma: a review. EA-R, EBNA, EBV, ELISA, NPC, VCA
1995 Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. APAAP, EBNA2, EBV, ISH, LMP, VCA
1995 First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. ---
10  1993 The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and B. EBV
11  1991 A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies. mAbs, NPC-EBV
12  1991 Mapping of the epitopes of Epstein-Barr virus gp350 using monoclonal antibodies and recombinant proteins expressed in Escherichia coli defines three antigenic determinants. EBV, mAbs
13  1989 [Studies on Epstein-Barr virus strain differences with monoclonal antibodies]. IF
14  1988 Development of an enzyme-linked immunosorbent assay (ELISA) for detecting IgA antibodies to the Epstein-Barr virus. EBV, ELISA, IF, mAb, NPC, VCA
15  1988 Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220. EBV, mAbs
16  1987 Detection of IgA antibody to EBV membrane antigen using Staphylococcus aureus preabsorbed sera is closely associated with nasopharyngeal carcinoma. EBV, NPC, SpA
17  1986 Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals. EBV
18  1986 Differential expression of Epstein-Barr virus membrane antigens defined with monoclonal antibodies. EBV, PAA, TPA
19  1986 Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals. EB, ELISA
20  1986 Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines. EA, EBV, VCA
21  1985 Biological activities of human recombinant interferon alpha/beta targeted by anti-Epstein-Barr virus monoclonal antibodies. EBV, IFN, mAb
22  1985 Immunofluorescence and electron microscopic investigations of epithelial hybrid cells derived from nasopharyngeal carcinoma (NPC-KT). EBV
23  1985 Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen. EBV, mAb
24  1985 Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine. EB, Mr
25  1985 The molecular biology of Epstein-Barr virus. EA, EBV, LYDMA, VCA
26  1984 A highly sensitive enzyme-linked immunosorbent assay to quantitate antibodies to Epstein-Barr virus membrane antigen gp340. EB, ELISA
27  1984 A sensitive enzyme-linked immunosorbent assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens. EA, EBV, ELISA, VCA
28  1984 A structural investigation of the Epstein-Barr (EB) virus membrane antigen glycoprotein, gp340. EB
29  1984 Antibody-dependent cellular cytotoxicity and disease course in North American patients with nasopharyngeal carcinoma: a prospective study. ADCC, EBV, NPC
30  1984 Antiviral and antiproliferative effects of interferons delivered via monoclonal antibodies. EBV, HuIFN-alpha, mAbs
31  1984 Comparative immunogenicity studies on Epstein-Barr virus membrane antigen (MA) gp340 with novel adjuvants in mice, rabbits, and cotton-top tamarins. ---
32  1984 [Studies on the synthesis of Epstein-Barr virus-related antigens induced by superinfection]. EA, EBV, MOI, VCA
33  1983 Glycosylation pathways of two major Epstein-Barr virus membrane antigens. EBV
34  1983 Monoclonal antibodies reactive with the surface and secreted glycoproteins of Marek's disease virus and herpesvirus of turkeys. HVT, MDV, mol. wt
35  1983 Purification and properties of the gp340 component of Epstein-Barr virus membrane antigen in an immunogenic form. EB
36  1983 Restrictions upon Epstein-Barr virus infection of the leukemic cell are demonstrated in patients with hairy cell leukemia. EBNA, EBV, HCL
37  1982 Expression of target antigen for Epstein-Barr virus-specific cytotoxic T cells on BJAB cells freshly infected with EBV. anti-beta 2M, EBV, LCL, LYDMA, MHC, Tc, UV
38  1982 Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein. EBV
39  1982 Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen. ---
40  1982 Purification and biologic characterization of a major Epstein Barr virus-induced membrane glycoprotein. ADCC
41  1982 Quantification of an Epstein-Barr virus-associated membrane antigen component. SDS-PAGE, TPA
42  1981 A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer. GMT, IF, IgA anti-MA
43  1981 Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates. EB
44  1981 Evidence for early membrane antigens in cytomegalovirus-infected cells. HCMV
45  1980 Antigenic difference between intracellular and membrane antigens induced by herpesvirus of turkeys. HVT, HVT, IA
46  1980 Blocking of immunofluorescence in the titration of membrane and intracellular reactive antibodies associated with herpesvirus of turkeys. HVT, IA, IF
47  1980 Demonstration of IgG EA (early antigen) and IgM MA (membrane antigen) antibodies in CMV infection of healthy infants and in those with liver disease. EA
48  1980 Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome. ADCC, PA
49  1980 IgM antibodies to Epstein-Barr virus-associated membrane antigen in sera of infectious mononucleosis patients. EBV, IM, VCA
50  1980 Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals. ADCC, EBNA, EBV
51  1980 Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides. EB, NPC, SDS-PAGE
52  1980 Seroconversion to virus-specific pre-early nuclear antigens in infants with primary cytomegalovirus infection. CMV, EA, LA, PENA
53  1979 Antibody-dependent cell-mediated cytotoxicity against Epstein-Barr virus membrane antigen in African Burkitt's lymphoma. ADCC, EBV
54  1979 Correlation between Epstein-Barr virus membrane antigen and three large cell surface glycoproteins. TPA
55  1979 Differences between early and late membrane antigens on cultured cells infected with herpesvirus of turkeys. EMA, HVT, IA, LMA
56  1979 Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. BL, EA, EBV, IM, mol. wt, NPC, VCA
57  1978 A novel surface antigen on lymphoid cells transformed by Epstein-Barr virus. SA
58  1978 Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus. EA, EBV, PA, VCA
59  1978 Demonstration of a surface antigen on Epstein-Barr virus genome-carrying lymphoid cells: distinction from the virus-determined membrane antigen. EBV, SA
60  1978 Papain solubilization of the Epstein-Barr virus-induced membrane antigen. EBV
61  1978 Potential for immunization against herpesvirus infections with plasma membrane vesicles. ---
62  1978 Solubilization and characterization of Herpesvirus saimiri-induced membrane antigens. ADLC, HVS
63  1977 A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatants. EBV
64  1977 Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development. ADCC, BL, EBV
65  1977 Membrane antigen expression in Epstein-Barr virus-infected Raji cells in the presence of phosphonoacetic acid. EBV, PAA
66  1977 Some factors affecting the expression of Epstein-Barr virus-associated membrane antigens. EBV, PHA
67  1977 Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease. EA, EBNA, EBV, VCA
68  1976 Antibody responses to membrane antigens in monkeys infected with Herpesvirus saimiri. ADLC, HSV, MF
69  1976 Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis. ADCC, IM
70  1976 Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens. ADLC, EBV, MF
71  1976 Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. I. Virus replication in lymphocytes infected with Friend virus and cultures in diffusion chambers in vivo. IC, MuLV
72  1976 Relation between common antigen and membrane antigens associated with Marek's disease herpesvirus and turkey herpesvirus infections. AGP, common-Ag, EMA, HVT, IF, LMA, MDHV
73  1975 Demonstration of a tumor-associated surface antigen in Marek's disease. MATSA, MD
74  1975 Ultraviolet inactivation of Epstein-Barr virus: effect on synthesis of virus-associated antigens. EA, EBV, UV, VCA
75  1972 EB-virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens(EA) in patients with various neoplastic conditions. EA, VCA